Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

NCT00352482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Pulmonary Fibrosis
Hypertension, Pulmonary

Interventions

DRUG: Sildenafil (50 mg)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)